Elucidating the cellular mechanism for E2-induced dermal fibrosis.
DeAnna Baker FrostAlisa SavchenkoAdeyemi OgunleyeMilton ArmstrongCarol Feghali-BostwickPublished in: Arthritis research & therapy (2021)
We conclude that E2-induced dermal fibrosis occurs in part through induction of TGFβ1, 2, and Col22A1, which is regulated through EGR1 and the MAPK pathway. Thus, blocking estrogen signaling and/or production may be a novel therapeutic option in pro-fibrotic diseases.